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Abstract 45 
Background: Obesity is a heterogeneous phenotype and risk associations to non-46 
communicable diseases such as cardiovascular disease and type 2 diabetes are influenced by 47 
several factors. The paternal metabolic status at the time of conception influences offspring 48 
susceptibility to developing obesity and adiposity-associated cardiometabolic disease. 49 
Cholestatic liver diseases are characterized by raised circulating serum bile acid levels and 50 
dyslipidemia, and are commonly treated with ursodeoxycholic acid (UDCA). We hypothesized 51 
that paternal cholestasis alters offspring susceptibility to developing obesity and adiposity-52 
associated cardiometabolic disease and that this may be modified by paternal UDCA treatment. 53 
Methods: Cholestasis was induced in male C57BL/6 mice with a 0.5% cholic acid (CA)-54 
supplemented diet for 10 weeks prior to mating with normal chow (NC)-fed females. Offspring 55 
of cholestatic and NC-fed fathers were fed either a NC diet or challenged with an obesogenic 56 
‘western diet’ (WD) from 12 weeks-old. Offspring body weight and cardiometabolic function 57 
were assessed, and the impact of treatment of paternal cholestasis with UDCA was evaluated.  58 
Results: Male offspring (18 weeks-old) of cholestatic fathers challenged with WD had raised 59 
fasting insulin, hepatic triglyceride content and serum cholesterol levels compared to diet-60 
matched controls.  At 25-29 weeks-old WD-fed male offspring of cholestatic fathers had higher 61 
systolic and diastolic blood pressure than controls and this was prevented by paternal UDCA 62 
treatment. In contrast, WD-challenged female offspring of cholestatic fathers showed improved 63 
glucose tolerance compared to controls.  64 
Conclusions: We demonstrated in our model of paternal cholestasis that offspring 65 
susceptibility to adiposity-associated cardiometabolic disease is affected in a sex-specific 66 
manner and paternal UDCA treatment had a protective effect against hypertension in the obese 67 
male offspring. The most prevalent human cholestatic conditions are primary sclerosing 68 
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cholangitis and primary biliary cholangitis. These findings are of clinical relevance to children 69 
of men with these conditions. 70 
  71 
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Introduction 72 
Currently there is a world-wide epidemic of non-communicable diseases (NCDs) such as 73 
cardiovascular disease and type 2 diabetes. Obesity is one of the main risk factors for 74 
cardiovascular disease and type 2 diabetes1. However, there is not a linear relationship between 75 
body mass and NCDs and additional factors may influence individual disease risk2. 76 
 77 
Accumulating evidence suggests that not only maternal health, but also the paternal metabolic 78 
status at the time of conception can impact the subsequent health of the offspring3. For example, 79 
paternal obesity has been associated with long-term alterations in body fat percentage of 80 
prepubertal daughters4 and early-onset paternal obesity is associated with raised alanine 81 
aminotransaminase (ALT) in the offspring5.  Food availability of grandfathers also impacts 82 
upon longevity and cardiovascular risk in the progeny, as reported in studies of a Swedish 83 
population6. 84 
 85 
Epigenetic marks in sperm may provide a mechanistic pathway through which offspring 86 
disease susceptibility can be altered, a hypothesis supported by studies in rodent models of 87 
paternal obesity, diabetes and manipulation of dietary folate7-9.  Changes in sperm DNA 88 
methylation, histone modifications and small RNA content have also been associated with 89 
increased disease susceptibility in offspring of fathers exposed to diet-induced obesity9-13, low-90 
protein diet14 or stress15, 16. Additionally, the paternal seminal plasma has been shown to 91 
influence the female oviduct cytokine expression profile and impact the offspring phenotype17. 92 
 93 
Cholestatic liver conditions are characterized by an impairment of bile acid efflux from the 94 
liver resulting in the accumulation of bile acids in the circulation concomitant with 95 
dyslipidemia18. The most common chronic cholestatic liver diseases affecting men are primary 96 
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sclerosing cholangitis and primary biliary cholangitis with a prevalence of up to 16.2 per 97 
100,000 persons and 40.2 per 100,000 persons respectively in the general population 19.  98 
 99 
We have previously reported that offspring exposed to maternal cholestasis during gestation 100 
are predisposed to developing increased adiposity, abnormal lipid profiles, diabetes and non-101 
alcoholic fatty liver disease20.  In addition, a previous study has shown that 4 months of 0.5% 102 
CA dietary supplementation to male mice resulted in reduced fertility, concomitant with 103 
decreased sperm count and smaller offspring litters. Further analysis showed that after 2 104 
months of CA diet, the blood-testis-barrier (BTB) was no longer intact and cell aggregates were 105 
visible in the centre of the seminiferous tubules and this was associated with decreased CX43 106 
accumulation in gap-junctions21. 107 
 108 
In this study, we used a mouse model to establish whether paternal cholestasis influences 109 
offspring susceptibility to developing obesity and adiposity-associated cardiometabolic 110 
disease.  As cholestatic conditions are typically treated with ursodeoxycholic acid (UDCA)18, 111 
we have also explored the effect of paternal cholestasis treatment with UDCA on offspring 112 
health. 113 
 114 
Materials and methods 115 
Animal experiments 116 
All procedures were approved by the Animal Welfare and Ethical Review Body at King’s 117 
College London and carried out according to the UK Animals (Scientific Procedures) Act 1986. 118 
Male and female C57BL/6 mice aged 6-8 weeks were purchased from Harlan Laboratories, 119 
UK. Mice were housed on a 12 h: 12 h light: dark cycle with ad libitum access to food and 120 
water. Male mice were assigned to either a RM3 normal chow (NC) diet (n = 6) or a RM3 diet 121 
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supplemented with 0.5% of cholic acid (CA) (n = 10) (LBS Serving Biotechnology, UK). Male 122 
mice were kept on the assigned diet for 10 weeks and body weight and food intake was 123 
measured weekly. Male mice fed a NC or CA diet were mated to NC-fed female mice of 124 
established fertility. Female mice used in the experiments had been previously mated and 125 
allowed to deliver 1 litter to establish fertility. During the mating period males were 126 
permanently kept with females and had access to ad libitum NC diet. Mating was confirmed 127 
by the presence of a copulatory plug, after which male mice were fasted for 4 h after 9 am and 128 
euthanized by CO2 inhalation. Serum, liver, gonadal white adipose tissue, subcutaneous white 129 
adipose tissue and testes were weighed and snap-frozen. Females were allowed to give birth 130 
and litters were left undisturbed for 24 h. On day 2, pup number per litter and pup weight were 131 
assessed and litters were standardized to 5-6 pups. Offspring body weight was measured 132 
weekly thereafter. Pups were kept on a NC diet from 3 to 12 weeks of age, at which point half 133 
of the male and female offspring from each litter were challenged with a calorie-rich western 134 
diet (WD) (LBS Serving Biotechnology, UK) until 18 weeks of age. The combination of 135 
paternal and offspring exposure resulted in 4 experimental offspring groups: NC NC, CA NC, 136 
NC WD, and CA WD (first two letters: paternal dietary exposure; second two letters: offspring 137 
dietary exposure) (Supplementary Figure 1). At 18 weeks of age, one male offspring (NC NC: 138 
n = 6, CA NC: n = 8, NC WD: n= 6, CA WD: n= 8) and one female offspring (NC NC: n= 4, 139 
CA NC: n = 8, NC WD n = 5, CA WD = 10) per litter were euthanized by CO2 inhalation after 140 
4 h of fasting from 9 am and tissues harvested as described above. In a second cohort, the 141 
paternal feeding experimental protocol was repeated and a group of male mice fed a 0.5% 142 
cholic acid + 0.5% ursodeoxycholic acid (CA+UDCA)-supplemented diet (LBS Serving 143 
Biotechnology, UK) was included (NC: n = 10, CA: n = 12, CA+UDCA: n = 9). Male offspring 144 
were fed a NC diet until 12 weeks of age and then transferred to WD. The 3 offspring groups 145 
according to paternal and offspring diet were NC WD, CA WD, CA+UDCA WD 146 
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(Supplementary Figure 2). Cardiovascular recordings were made in male offspring (25-29 147 
weeks) by radiotelemetry (NC: n = 4, CA: n = 3, CA+UDCA: n = 4) (see below).  148 
 149 
Glucose tolerance test (GTT) 150 
At 18 weeks of age one male (NC NC: n = 6, CA NC: n= 8, NC WD: n = 6, CA WD: n= 8) 151 
and one female offspring (NC NC: n = 4, CA NC: n = 8, NC WD: n= 4, CA WD: n = 8) per 152 
litter were fasted for 6 h from 9 am followed by an intraperitoneal injection of 2 g/kg of D-153 
glucose (Sigma-Aldrich, UK). Blood glucose was measured using a glucometer (AccuCheck, 154 
UK) before glucose injection and 15, 30, 45, 60 and 120 min following glucose injection. Tail 155 
blood samples were collected prior to glucose injection and 30 minutes after glucose injection 156 
for serum insulin measurements. Area under the curve (AUC) was calculated from the 157 
measurements from each mouse from before the start of GTT until 120 minutes following 158 
glucose injection. 159 
 160 
Radiotelemetry 161 
Systolic blood pressure, diastolic blood pressure, heart rate and activity were measured in 1 162 
male offspring per litter after surgical implantation of probes (Data Sciences International, 163 
USA) in the carotid artery (see supplementary information). Measurements are represented 164 
over a 24 h period in zeitgeber time where ZT 0 to ZT 12 is lights-on in the animal colony and 165 
ZT 12 to ZT 24 (ZT 0) is lights-off. Light and dark cycle averages were calculated based on 166 
the hourly averages taken between ZT 0 - ZT 11 and ZT 12 - ZT 24 respectively. 167 
 168 
Insulin measurements 169 
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Measurements of serum insulin from blood samples taken before the start of GTT and 30 170 
minutes after the start of GTT were undertaken using the Mercodia Mouse Insulin ELISA 171 
(Mercodia, Sweden) according to the manufacturer’s protocol. 172 
 173 
Lipid measurements 174 
Lipids were extracted from frozen liver samples using a lysis buffer containing 0.125M 175 
potassium phosphate. Serum and lipids were run on a Unicel DxC 800 autoanalyzer (Beckman-176 
Coulter, the Netherlands) for measurements of total cholesterol, LDL-cholesterol, HDL-177 
cholesterol, triglycerides and free fatty acids as previously described22.  178 
 179 
Total RNA extraction and cDNA synthesis 180 
Total RNA was extracted from frozen tissue samples using the RNeasy Mini kit (Qiagen, UK) 181 
according to manufacturer’s instructions. For cDNA synthesis, total RNA was reverse 182 
transcribed using SuperScript™ II Reverse Transcriptase (Thermo Fisher Scientific, UK). 183 
RNase inhibition was used to prevent RNA digestion.  184 
 185 
Quantitative Real Time-PCR 186 
The expression of target genes of interest was assessed using quantitative RT-PCR with a 187 
ViiA™ 7 Real Time PCR System (Thermo Fisher Scientific, UK). cDNA was added in 188 
duplicate followed by a reaction mix containing 1X of SYBR Green Jumpstart Readymix 189 
(Sigma-Aldrich, UK) and 1 μM of forward/reverse primers. The housekeeping gene 190 
Cyclophilin b was used as an internal reference for cDNA quality and relative quantification of 191 
gene expression. The genes assessed included ATP-binding cassette sub-family G member 5 192 
and 8 (Abcg5 and Abcg8), Acetyl-CoA carboxylase 1 and 2 (Acc1 and Acc2), bile salt export 193 
pump (Bsep), cholesterol 7-alpha-monooxygenase (Cyp7a1), sterol 12-alpha-hydroxylase 194 
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(Cyp8b1), fatty acid synthase (Fas), HMG-CoA reductase (Hmgcr), stearoyl-CoA desaturase 195 
(Scd1), small heterodimer partner (Shp), sterol regulatory element-binding protein 1c (Srebp-196 
1c). Primer sequence list is provided in Supplementary Table 1. 197 
 198 
Statistical analysis 199 
Data are presented as mean ± SEM. Statistical analysis was performed using GraphPad Prism 200 
7 software (GraphPad Software Inc., USA). Data was checked for normality using the Shapiro-201 
Wilk normality test. Repeated measures of one-way ANOVA followed by a Newman-Keuls 202 
post-hoc test or two-way ANOVA followed by a Tukey post-hoc test were applied for multiple 203 
comparisons. For single comparisons unpaired 2-tailed t-test was used. The significance cut-204 
off was P ≤ 0.05. 205 
 206 
Results 207 
Cholestasis lowers paternal body weight and causes dyslipidemia 208 
We first established the effect of cholestasis induced by 10 weeks of 0.5% CA feeding on the 209 
paternal phenotype. CA-fed fathers were lighter than controls over the duration of the feeding 210 
period (Figure 1A) and this was not explained by lower daily food intake (Figure 1B). After 10 211 
weeks of CA feeding, liver size was increased by 44% in cholestatic males whereas gonadal 212 
(gWAT) and subcutaneous white adipose tissue (sWAT) weight decreased by 58% and 18% 213 
respectively (Figure 1C). No changes were observed in testis weight (Figure 1C). Time to mate 214 
was not different between fathers from NC and CA groups (4.89 ± 1.4 vs 3.33 ± 0.67 days 215 
respectively) (Supplementary Figure 3). 216 
 217 
CA feeding caused an aberrant paternal lipid profile, with raised serum total cholesterol and 218 
LDL-cholesterol levels (Figure 1D) and increased hepatic cholesterol content (Figure 1E). 219 
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Serum and hepatic triglycerides and free fatty acids (FFAs) concentrations were not altered by 220 
CA feeding (Figure 1D, E).  221 
 222 
Investigation of the hepatic expression of key genes regulating bile acid homeostasis showed a 223 
pro-cholestatic profile with increased hepatic expression of the farnesoid x receptor (FXR) 224 
target Shp and reduced expression of Cyp8b1 as compared to controls (Figure 1F). Moreover, 225 
trends for increased expression of Bsep and decreased expression of Cyp7a1 were observed. 226 
 227 
Offspring litter size, birth weight and morphometry 228 
Birthweight and number of pups per litter was not altered by paternal cholestasis (Figure 2A, 229 
B). 230 
 231 
Challenge with a WD resulted in an overall increase in male and female offspring body weight, 232 
as well as liver, gWAT, sWAT, and brown adipose tissue (BAT) weight in males (Figure 2C, 233 
E, F, H). A decrease in food intake in WD-fed males and females as compared to NC-fed 234 
offspring was also observed (Figure 2D, G). 235 
 236 
 Despite no differences in total body weight or food intake when compared to NC WD controls 237 
(Figure 2C, D), 18 week-old WD-fed male offspring of cholestatic fathers (CA WD) showed a 238 
29% increase in liver weight and a 26% decrease in sWAT weight (Figure 2E). These changes 239 
were not observed when male offspring were maintained on a NC diet.  240 
 241 
Female offspring of cholestatic fathers fed a NC or WD did not show significant changes in 242 
body weight when compared to female progeny of control fathers fed a matched diet (Figure 243 
2F). However, at 6 weeks of age female offspring of CA fathers (CA NC) had decreased daily 244 
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food intake, a trend which persisted until 16 weeks of age (Figure 2G). No differences in organ 245 
weight were observed between female offspring of cholestatic and control fathers when fed 246 
matched diets (Figure 2H).  247 
 248 
Overall, these results suggest that challenge with a calorie-rich diet affects male and female 249 
offspring of cholestatic fathers differently with males being more susceptible to changes in 250 
organ morphometry. 251 
 252 
Paternal cholestasis has distinct effects on glucose homeostatic responses to western diet in 253 
male and female offspring 254 
A glucose tolerance test (GTT) was performed at 18 weeks of age, and circulating insulin was 255 
measured prior to glucose injection, and 30 min after glucose injection. Male CA WD offspring 256 
showed a trend towards higher blood glucose levels compared to matched NC WD offspring 257 
during the GTT (Figure 3 A, B). CA WD male offspring also had significantly raised fasting 258 
insulin levels compared to NC WD controls (3.9 ± 0.9 vs 2.5 ± 0.2 ng/mL, respectively) (Figure 259 
3C). Thirty minutes after the GTT, a trend for increased insulin levels was still observed. No 260 
differences were seen in CA NC compared to NC NC offspring.  261 
 262 
 In contrast to male offspring, female WD-fed offspring of CA fathers showed improved 263 
glucose tolerance compared to NC WD at 30 and 45 minutes of the GTT challenge (Figure 264 
3D). Consistent with the GTT results, the AUC was 14% lower in CA WD female offspring 265 
compared to NC WD females (Figure 3E). At the measured time-points, serum insulin levels 266 
were not different between CA WD and NC WD females (Figure 3F). No differences were 267 
observed in female offspring fed a NC diet.  268 
 269 
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Overall, male and female offspring of CA fathers showed distinct glucose homeostasis 270 
phenotypes. Specifically, male CA WD offspring have increased fasting insulin when exposed 271 
to WD whereas female offspring seem to be protected, to some extent, against WD-induced 272 
impairments in glucose tolerance. 273 
 274 
Paternal cholestasis affects lipid homeostasis in response to western diet differently in male 275 
and female offspring 276 
We next investigated the serum and hepatic lipid profiles in the offspring of cholestatic fathers. 277 
WD-fed male offspring of cholestatic fathers had 43% higher levels of circulating total 278 
cholesterol, including a 62% increase in LDL-cholesterol and a 60% rise in HDL-cholesterol 279 
as compared to NC WD (Figure 4A). However, the changes observed were not attributable to 280 
an increase in hepatic gene expression of Hmgcr, the rate-limiting enzyme for cholesterol 281 
synthesis, or the cholesterol exporters from the liver Abcg5 and Abcg8 (Figure 4C). In addition 282 
to raised circulating cholesterol, CA WD males had a 30% increase in hepatic triglyceride 283 
content compared to NC WD controls (Figure 4B). These findings were consistent with an 284 
increase in the hepatic expression of enzymes involved in key steps of fatty acid synthesis, i.e. 285 
Fas and Scd1 that were raised by 0.9 and 1.2-fold respectively (Figure 4C). Enhanced synthesis 286 
and storage of FFAs as triglycerides are likely to contribute to the increased hepatic triglyceride 287 
content in CA WD progeny. No changes in serum or hepatic lipids were seen in NC-fed male 288 
offspring.  289 
 290 
In female CA WD and CA NC offspring, no changes in serum or hepatic lipid levels were 291 
found when compared to controls fed a matched diet (Figure 4D, E). However, a decrease in 292 
the hepatic gene expression of Srebp-1c, Scd1, Acc1 and Acc2, involved in controlling fatty 293 
acid biosynthesis, was seen in CA WD females as compared to NC WD controls (Figure 4F).  294 
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 295 
Our results demonstrate that while male CA WD progeny have increased lipid accumulation in 296 
the liver and circulation, female offspring do not show a worsened lipid metabolic phenotype 297 
as a result of WD. 298 
 299 
Paternal cholestasis increases the risk of obesity-associated hypertension in male offspring 300 
and paternal UDCA treatment prevents rises in blood pressure  301 
Since CA WD male offspring showed several adiposity-associated cardiovascular risk factors, 302 
we next interrogated the effects of paternal cholestasis on the cardiovascular phenotype of the 303 
obese male offspring.  304 
 305 
The phenotype of fathers fed a CA+UDCA diet was largely similar to that of CA-fed fathers 306 
except for higher serum lipids, and a further suppression in the expression of the bile acid 307 
synthesis genes Cyp7a1 and Cyp8b1 compared to NC controls (Supplementary Figure 4). 308 
 309 
At 25-29 weeks of age, CA WD male offspring displayed a significant increase in systolic 310 
blood pressure at ZT 10, ZT 12, ZT 21 and ZT 22 (Figure 5A). Significant elevations of 311 
diastolic blood pressure were also registered in CA WD males at ZT 10, ZT 12, and ZT 21 312 
compared to NC WD controls (Figure 5B). In contrast, CA+UDCA WD males had blood 313 
pressure levels comparable to those observed in NC WD controls. In particular, at ZT 10, ZT 314 
21 and ZT 22 systolic blood pressure of CA+UDCA WD males was significantly lower than 315 
CA WD counterparts and comparable to NC WD controls (Figure 5A). Diastolic blood pressure 316 
was also lower in CA+UDCA WD male offspring than CA WD males at ZT 10, ZT 12, and 317 
ZT 21 and did not differ from NC WD controls (Figure 5B). There were no significant 318 
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differences in heart rate between progeny groups (Figure 5C), although NC WD male offspring 319 
were significantly more active than CA WD and CA+UDCA WD males at ZT 14 (Figure 5D).  320 
 321 
Despite the cardiovascular observations, no significant changes were seen in these older mice 322 
in body weight, liver weight or lipid profiles in CA WD and CA+UDCA WD males as 323 
compared to NC WD controls, although there was a trend for increased liver weight 324 
(Supplementary Figure 5). 325 
 326 
These data indicate that paternal cholestasis is linked to increased predisposition of male 327 
offspring to developing obesity-associated hypertension, whereas paternal UDCA treatment of 328 
cholestasis can protect against hypertension in the offspring. 329 
 330 
Discussion 331 
This study has shown that paternal cholestasis is linked to increased susceptibility to adiposity-332 
associated metabolic and cardiovascular disease in the male offspring, and that paternal UDCA 333 
treatment can prevent the development of obesity-associated hypertension in the male 334 
offspring.  335 
 336 
Offspring of cholestatic fathers did not show a disease-prone phenotype compared to controls 337 
until challenged with an obesogenic diet, which differentially affected male and female 338 
offspring and resulted in contrasting metabolic phenotypes at 18 weeks of age. When fed the 339 
same calorie-rich diet, male offspring of cholestatic fathers showed features associated with 340 
the initial stages of metabolic disease, including higher fasting insulin levels and enlarged livers 341 
with increased hepatic triglyceride content. We also observed an increase in hepatic Fas and 342 
Scd1 expression, markers of lipogenesis. Raised insulin levels and enhanced lipogenesis with 343 
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hepatic triglyceride formation have been previously been associated with the development of 344 
non-alcoholic fatty liver disease, where hepatocytes become insulin resistant and fail to repress 345 
lipogenesis and triglyceride accumulation in response to high insulin levels23, 24. Moreover, CA 346 
WD males showed a decrease in sWAT mass concomitant with hepatic TG accumulation that 347 
could be due to impaired sWAT expansion, as TGs have been shown to accumulate in the liver 348 
and muscle in the absence of functional adipocytes25. Males fed a WD also had higher serum 349 
cholesterol levels, but with no apparent increase in hepatic cholesterol biosynthesis or export.  350 
 351 
Given the cardiovascular risk factors observed in the CA WD offspring, we used radiotelemetry 352 
to investigate the cardiovascular phenotype of older obese male offspring of cholestatic fathers, 353 
after being exposed to a WD for over 13 weeks. The male CA WD offspring showed an 354 
elevation of both systolic and diastolic blood pressure. However, in offspring of cholestatic 355 
fathers treated with UDCA, systolic and diastolic blood pressure levels were comparable to NC 356 
WD controls. These data show that treatment of cholestatic fathers with UDCA was effective 357 
in preventing the development of obesity-associated hypertension in male offspring beyond the 358 
levels registered in control NC WD offspring. No increase in heart rate was observed in male 359 
CA WD and CA+UDCA WD offspring compared to controls, suggesting that the baroreceptor 360 
reflex remained sensitive to raises in blood pressure.   361 
 362 
The mechanisms underlying the increased adiposity-associated cardiometabolic disease 363 
susceptibility observed in the male offspring of cholestatic fathers and the protective effect 364 
given by paternal UDCA treatment against diet-induced hypertension are unknown but may 365 
involve persistent alterations in the paternal sperm epigenome, as observed in previous studies7-366 
10, 12, 15, 16, 26, 27. Future studies will address potential changes in the sperm epigenome of 367 
cholestatic fathers and cholestatic fathers treated with UDCA that may affect the embryonic 368 
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developmental trajectory and alter the phenotype of the adult offspring. In addition, 369 
investigation of the effects of paternal UDCA administration alone will be pursued to elucidate 370 
the protective effect of UDCA treatment of paternal cholestasis against obesity-associated 371 
hypertension in the offspring.   372 
 373 
In contrast to male offspring, CA WD female offspring showed improved glucose tolerance 374 
compared to matched controls, in parallel with a decrease in the hepatic expression of the 375 
lipogenic genes Srebp-1c, Scd1, Acc1 and Acc2.  Overall, these data suggest that protective 376 
mechanisms may be in place in female offspring of cholestatic fathers to counteract the 377 
negative effects of exposure to WD feeding. Discrepancies between male and female offspring 378 
phenotypes have previously been reported in rodent models of paternal exposure to low-protein 379 
diet and obesity 10, 11, 28. However, the mechanisms underlying the sexual dimorphism found in 380 
these models have not been described. Sex-specific effects have also been observed in models 381 
of fetal exposure to an adverse intrauterine environment. For example, in a rodent model of 382 
placental insufficiency, sex-specific effects on the cardiovascular phenotype of the offspring 383 
have been linked to reproductive hormones including estrogen and testosterone 29. Moreover, 384 
sex chromosomes and genomic imprinted regions may play a role in influencing the 385 
developmental trajectory of the offspring. For example, in murine embryonic stem cells, sex 386 
chromosome complement alone has been associated with DNA methylome-wide differences30 387 
and with differential autosomal expression of coding and non-coding RNA 31. In addition, 388 
differential expression of imprinted loci has been observed in male and female murine 389 
embryonic stem cells, despite maintaining correct parental imprinting patterns 31 and studies 390 
performed on the liver of adult mice have shown sex-dependent genome imprinting effects that 391 
were correlated to complex traits such as body and liver weight 32. A further study has identified 392 
1184 differentially methylated CpG sites between men and women, enriched at imprinted genes 393 
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and distributed across all autosomes 33. It is thus possible that changes to the paternal 394 
epigenome may interact with different factors present in the early embryo and later in life, 395 
including the sex chromosomes, genomic imprinted regions and reproductive hormones, to 396 
differently modulate the embryonic developmental trajectory and adult metabolic phenotype 397 
of male and female offspring from cholestatic fathers. 398 
 399 
A limitation of the study is that during the mating period the paternal CA diet was discontinued 400 
and thus circulating BA levels would have gradually decreased in the CA group over the mating 401 
period. This would explain less marked changes in hepatic Cyp7a1 and Bsep expression than 402 
would be anticipated. It was necessary to discontinue the paternal CA diet during the mating 403 
period to avoid exposing females to CA, which has previously been shown to influence the 404 
offspring phenotype later in life 20. However, mean time to mate was approximately 3 days in 405 
the CA group and fathers would still have a significant derangement in BA and lipid levels 406 
caused by 10 weeks of CA feeding at the time of mating. Another possible caveat of the study 407 
is that implantation of the radiotelemetry probe has previously been shown to result in weight 408 
loss in mice for up to 15 days34 and may have influenced the metabolic phenotype of the male 409 
offspring. 410 
 411 
It is also important to note that CA feeding of fathers resulted in a lower paternal body weight 412 
despite causing hepatomegaly and dyslipidemia. Previous models of bile acid feeding have 413 
reported similar findings with liver enlargement secondary to increased hepatocyte size, 414 
dilation of interlobular bile ducts, parenchymal mitosis and inflammation in the liver35, 36. 415 
Dyslipidemia is also a feature of cholestasis since repression of Cyp7a1 expression, an enzyme 416 
which catalyzes bile acid synthesis from cholesterol, results in hepatic cholesterol 417 
accumulation 37. The observation that CA-fed fathers had smaller white adipose depots (gWAT 418 
19 
 
and sWAT) was consistent with the decreased body weight in fathers throughout the CA 419 
feeding period. Rather than losing weight, CA-fed fathers appeared unable to gain weight at 420 
the same rate as controls, findings which align with a previous report of lower body weight in 421 
mice exposed to CA feeding for 102 days38. 422 
 423 
In conclusion, paternal cholestasis is associated with sex-specific effects on offspring 424 
susceptibility to metabolic disease and male progeny present a more disease-prone phenotype 425 
with features of metabolic disease and hypertension when exposed to an obesogenic diet. 426 
Paternal UDCA treatment has a protective effect against the exacerbation of obesity-associated 427 
hypertension in male offspring. The most prevalent cholestatic diseases in humans are primary 428 
sclerosing cholangitis and primary biliary cholangitis and UDCA is a common treatment for 429 
these conditions18. The results presented in this study warrant investigations into the metabolic 430 
and cardiovascular phenotype of children of fathers with primary sclerosing cholangitis and 431 
primary biliary cholangitis, who may be taking UDCA at the time of conception of their child. 432 
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Figure legends 593 
Figure 1 - Paternal morphometry and metabolic profile. (A) Paternal body weight during 594 
feeding period. n = 6 - 10. (B) Paternal daily food intake during feeding period. n = 6 - 10. (C) 595 
Paternal organ weight. n = 6 – 10. (D) Paternal serum lipid levels. n = 6. (E) Paternal hepatic 596 
lipid levels. n = 6 (F) Paternal hepatic expression of bile acid homeostasis genes. n = 6.  Data 597 
are presented as mean ± SEM. * P ≤ 0.05. Unpaired 2-tailed t-test was used. 598 
 599 
Figure 2 - Offspring birth parameters and morphometry later in life. (A) Offspring birth weight. 600 
n = 6 – 10. (B) Offspring pup number per litter. n = 6 – 10. (C) Male offspring body weight 601 
from 1 to 18 weeks of age. n = 6 – 10. (D) Male offspring mean average daily food intake from 602 
4 to 17 weeks of age. n = 6 – 10. (E) Male offspring organ weight. n = 6 – 8. (F) Female 603 
offspring body weight from 1 to 18 weeks of age. n = 4 –10. (G) Female offspring mean daily 604 
food intake from 4 to 17 weeks of age. n = 4 – 10. (H) Female offspring organ weight. n = 4 - 605 
10. Data are presented as mean ± SEM. * P ≤ 0.05 for effects due to WD challenge in 606 
comparisons vs NC NC and CA NC; # P ≤ 0.05 for effects due to paternal cholestasis in 607 
comparisons of NC NC vs CA NC or NC WD vs CA WD. Repeated measures of one-way 608 
ANOVA followed by a Newman-Keuls post-hoc test was used. 609 
 610 
Figure 3 - Glucose homeostasis in offspring. (A, B) Glucose tolerance test (GTT) and area 611 
under the curve (AUC) in male offspring. n = 6 – 8. (C) Measurement of insulin levels in male 612 
offspring prior to and 30 minutes after glucose injection. n = 6 - 8. (D, E) Glucose tolerance 613 
test (GTT) and area under the curve (AUC) in female offspring. n = 4 – 8. (F) Measurement of 614 
insulin levels in female offspring prior to and 30 minutes after glucose injection. n = 4 – 8. 615 
Data are presented as mean ± SEM. * P ≤ 0.05 for effects due to WD challenge in comparisons 616 
vs NC NC and CA NC; & P ≤ 0.05 for effects due to WD challenge in comparisons vs NC NC; 617 
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$ P ≤ 0.05 for effects due to WD challenge in comparisons vs CA WD; # P ≤ 0.05 for effects 618 
due to paternal cholestasis in comparisons vs NC WD. Repeated measures of two-way 619 
ANOVA followed by a Tukey post-hoc test was used on GTT data comparisons, repeated 620 
measures of one-way ANOVA followed by a Newman-Keuls post-hoc test was used on AUC 621 
and insulin measurements data. 622 
 623 
Figure 4 - Serum and hepatic lipid profiles in offspring. (A) Serum lipid levels in male 624 
offspring. n = 6. (B) Hepatic lipid levels in male offspring. n = 6. (C) Hepatic expression of 625 
lipid homeostasis genes in male offspring. n = 6. (D) Serum lipid levels in female offspring. n 626 
= 4 – 6. (E) Hepatic lipid levels in female offspring. n = 4 – 6. (F) Hepatic expression of lipid 627 
homeostasis genes in female offspring. n = 4 – 6. Data are presented as mean ± SEM. * P ≤ 628 
0.05 for effects due to WD challenge in comparisons vs NC NC and CA NC; # P ≤ 0.05 for 629 
effects due to paternal cholestasis in comparisons vs NC WD. Repeated measures of one-way 630 
ANOVA followed by a Newman-Keuls post-hoc test was used. 631 
 632 
Figure 5 - Effect of paternal cholestasis and ursodeoxycholic acid (UDCA) treatment of 633 
paternal cholestasis on cardiovascular parameters in the offspring. (A) Male offspring systolic 634 
blood pressure over a 24 h period and mean systolic blood pressure during the light and dark 635 
cycles. (B) Male offspring diastolic blood pressure over a 24 h period and mean diastolic blood 636 
pressure during the light and dark cycles. (C) Male offspring heart rate over a 24 h period and 637 
mean heart rate during the light and dark cycles (D) Male offspring activity over a 24 h period 638 
and mean activity during the light and dark cycles. Data are presented as mean ± SEM. n = 3 – 639 
4. # P ≤ 0.05 for effects due to paternal cholestasis in comparisons vs NC WD; † P ≤ 0.05 for 640 
effects due to untreated paternal cholestasis in comparisons vs CA+UDCA WD; ‡ for effects 641 
due to paternal UDCA treatment in comparisons vs CA WD. Repeated measures of two-way 642 
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ANOVA followed by a Tukey post-hoc test was used on 24 h recordings data comparisons, 643 
repeated measures of one-way ANOVA followed by a Newman-Keuls post-hoc test was used 644 
on mean light and dark cycle comparisons. 645 
 646 
